Home Antibody All anti-SART3 antibodies
Also for SART3 (NM_014706)
| Peptide with sequence C-MSNADFAKLFLRK, from the C Terminus of the protein sequence according to NP_055521.1.|
|Test: Human. Expected from seq similarity: Human
||ELISA: 1:16,000. WB: 0.01-0.03µg/ml.
|Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.|
| Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.
|Homo sapiens squamous cell carcinoma antigen recognized by T cells 3 (SART3)|
|DSAP1; P100; p110; p110(nrb); RP11-13G14; TIP110|
|The protein encoded by this gene is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. This gene product is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This encoded protein is thought to be involved in the regulation of mRNA splicing. [provided by RefSeq]. |
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
TA302846 staining (0.01µg/ml) of Jurkat cell lysate (RIPA buffer, 30µg total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.